“Upon closing, we expect to record a charge of approximately $7 billion, the majority of which is non-cash and largely due to foreign currency translation losses accumulated over several years.”

In context

“tivity, and further enhance the consumer experience at both Optum and UnitedHealthcare. And now, I'll turn it over to John Rex, UnitedHealth Group's, Chief Financial Officer. John? John Rex: Thank you, Dirk. Our colleagues' ongoing focus on further expanding and strengthening the foundations, which underpinned our growth pillars is paving the way for consistent growth in 2024 and beyond. Revenue in ‘23 of $372 billion grew by over 14% with double-digit growth at both Optum and UnitedHealthcare. Fourth quarter adjusted earnings per share of $6.16, grew 15% and brought full-year adjusted earnings per share to $25.12, a growth of 13%. As Andrew noted earlier, at the end of December, we entered into an agreement to sell our Brazil operations and expect to close in the first-half of this year. Upon closing, we expect to record a charge of approximately $7 billion, the majority of which is non-cash and largely due to foreign currency translation losses accumulated over several years. The impact of this one-time charge will be excluded from our ‘24 adjusted earnings per share measure. For your modeling purposes, the full-year ‘24 outlook incorporated about $6 billion of revenue for Brazil or about 1.5% of consolidated revenue. Before reviewing our business results, I'll offer some brief comments on care activity. Care patterns remain consistent with those we shared with you in the first-half of ‘23. Activity levels continue to be led by outpatient care for seniors with orthopedic and cardiac procedure categories among the more prominent. As we've noted, our benefit design approach assumed these activity levels persist throughout ‘24. And the care patterns we observed exiting ‘23 reconfirmed that decision. On the margin, we saw some modest late-year seasonal activity, s”